MPAC conclusions and recommendations: April 2019

MPAC conclusions and recommendations: April 2019

On 10–12 April 2019, the World Health Organization (WHO) Malaria Policy Advisory Committee (MPAC) convened to review updates and progress in malaria control and elimination, and to provide guidance on specific thematic areas of work carried out by the Global Malaria Programme (GMP). The meeting’s eight sessions focused on 11 topics including: 7 updates for guidance (the “High burden to high impact” approach; malaria elimination in the Greater Mekong Subregion; the Strategic Advisory Group on malaria eradication; the GMP policy-making and dissemination process; the Evidence Review Group on mass drug administration; the Malaria Elimination Oversight Committee and STOP-Malaria; the outcome of the technical consultation on external competence assessment for malaria microscopy); 2 updates for information (drug efficacy and resistance; and the Evidence Review Group on malariogenic potential); one update for approval (the RTS,S Malaria Vaccine Implementation Programme and framework for decision-making); and one new process for approval (prioritization of new topics for policy recommendation development).